Biedermann, Luc http://orcid.org/0000-0003-0824-4125
Straumann, Alex http://orcid.org/0000-0002-1428-6404
Article History
Accepted: 14 September 2022
First Online: 17 October 2022
Competing interests
: L.B. reports fees for consulting/advisory board from Abbvie, Amgen, BMS, MSD, Vifor, Falk, Esocap, Janssen, Calypso, Ferring, Pfizer, Takeda, Janssen and Sanofi. A.S. has consulting contracts with Astra-Zeneca, Bristol-Myers-Squibb, EsoCap, Falk Pharma, GSK, Pfizer, Receptos-Celgene and Regeneron-Sanofi; none of these contracts is critical regarding this article.